Similarly, it was shown that IGFBP3 can inhibit HCC cell proliferation by suppressing transcription of early growth response protein 1 (EGR1) and its target genes basic fibroblast growth factor (bFGF) and platelet-derived growth factor (PDGF) (99). Here, EGR1 is linked to hepatocellular carcinoma.